Petrova Penka

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return12%16%0%0%0%
Sale Success Rate4 of 42 of 40 of 40 of 40 of 4

Trillium Therapeutics Inc.

Other » Other

Chief Development Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--